Q BioMed Inc (NASDAQ:QBIO) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Wednesday.

According to Zacks, “Q BioMed Inc. is a biomedical acceleration and development company. It focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. Q BioMed Inc. is based in New York. “

Q BioMed (NASDAQ:QBIO) opened at 3.00 on Wednesday. Q BioMed has a 1-year low of $1.26 and a 1-year high of $6.00. The firm’s market cap is $27.25 million. The stock has a 50 day moving average price of $3.41 and a 200-day moving average price of $3.10.

Q BioMed Company Profile

Q BioMed, Inc, formerly ISMO Tech Solutions, Inc, is a biomedical acceleration and development company. The Company is focused on licensing, acquiring and providing strategic resources to life sciences and healthcare companies. The Company intends to acquire multiple assets over time and across a spectrum of healthcare related products, companies and sectors.

5 Day Chart for NASDAQ:QBIO

Receive News & Stock Ratings for Q BioMed Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Q BioMed Inc and related stocks with our FREE daily email newsletter.